Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on RHOEN-KLINIKUM AG. We currently have 2 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
Waiting for a growing margin excluding non-recurring items
19 May 16
Rhön Kinikum’s Q1 16 results showed sales of €291.5m (+5.6% reported, 2.5% lfl), EBITDA of €67.9m (+36.6% reported, +3% excluding non-recurring items), EBIT of €53.2m (+53.8% reported; +5.5% excluding non-recurring items) and net income of €49.9m (group share, +55% reported). These figures included the acquisition of Kreisklinik Bad Neustadt, consolidated for the first time from 1 January 2016, as expected. This acquisition increased capacity by 4.5% (+233 beds), to reach 5,451 beds. The group maintains its FY16 targets of revenues of €1.17-1.1.2bn and EBITDA of €155-165m.
H1 15 in line, a small acquisition and a share buy-back soon
06 Aug 15
Rhön Kinikum’s H1 15 results show sales of €555.4m, EBITDA of €83.8m, EBIT of €53.8m and net income of €48.6m (group share). Note figures are of course not comparable to last year’s given the huge change in scope after the disposal of the hospitals sold to Fresenius/Helios and still consolidated over two months in H1 14. The group maintains its target for FY15 of revenues of €1.08-1.12bn and EBITDA of €145-155m.
N+1 Singer - Small-cap quantitative research - Momentum screen refresh + 10 focus stocks
12 Jan 17
We have refreshed our momentum style screen for the first time since inception on 26 July 2016. As before, the screen selects the 25 stocks exhibiting the most extreme momentum characteristics, according to our measurement method. From these we have selected 10 to focus on. Since inception the screen has underperformed both the main small-cap and micro-cap indices against a background of generally rising momentum. We have noted a subset of the basket, where decelerating momentum at the time of measurement appears correlated with significant share price falls since selection. We shall monitor this factor with the new screen, albeit there are only two such stocks showing this pattern, namely Lamprell (not rated) and Gear4music (not rated).
N+1 Singer - Morning Song 12-01-2017
12 Jan 17
As anticipated, the second half has again been stronger than H1 and results will be broadly in line with expectations. In line with this, the order book has continued to grow and is at record levels. This confirms that significant progress has been made in the Group’s shift towards its Technology Products division which, as targeted, contributed c.60% of group revenue in FY16. The small acquisition of Cable Power also gives a complementary boost to the product range. It is also worth noting the significant reduction in net debt, £1.0m ahead of our forecast. We remain supportive of the Group’s strategy and continue to see a bright future as this transition towards a design led technology solutions business continues. We look forward to more detail in March at the final results.
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.
The Monthly January 2017
09 Jan 17
Despite all the hullaballoo of the Brexit vote and the subsequent election of Donald Trump as the next US President, the UK stock market prospered last year, especially in the latter few months of 2016. The combination of a depreciating currency – making $ earnings more valuable in relative terms - and the Trump emphasis on infrastructure expenditure drove the stock market higher
11 Jan 17
Joules Group (JOU): Strong festive trading (BUY) | Shoe Zone (SHOE): Tough FY16 could be just the beginning (HOLD) | H&T (HAT): Alternative lender emerging (BUY) | Omega Diagnostics* (ODX): ISO accreditation received for Pune, India (CORP) | Redcentric* (RCN): Interims – restoring forecasts (CORP)
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.